BICEVO Trademark

Trademark Overview

On Wednesday, August 18, 2021, a trademark application was filed for BICEVO with the United States Patent and Trademark Office. The USPTO has given the BICEVO trademark a serial number of 90889071. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, March 25, 2025. This trademark is owned by Genentech, Inc.. The BICEVO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in oncology
bicevo

General Information

Serial Number90889071
Word MarkBICEVO
Filing DateWednesday, August 18, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, March 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements

Goods and Servicespharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Saturday, August 21, 2021NEW APPLICATION ENTERED
Wednesday, October 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 7, 2022ASSIGNED TO EXAMINER
Monday, March 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 25, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 26, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 19, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, May 16, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 16, 2023SOU EXTENSION 2 FILED
Tuesday, May 16, 2023SOU EXTENSION 2 GRANTED
Thursday, May 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 20, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 20, 2023SOU EXTENSION 3 FILED
Monday, November 20, 2023SOU EXTENSION 3 GRANTED
Wednesday, November 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 29, 2024SOU EXTENSION 4 GRANTED
Wednesday, May 29, 2024SOU EXTENSION 4 FILED
Thursday, May 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2024SOU EXTENSION 5 FILED
Tuesday, December 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 25, 2025SOU EXTENSION 5 GRANTED
Tuesday, March 25, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 26, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 26, 2022SOU EXTENSION 1 FILED
Wednesday, October 26, 2022SOU EXTENSION 1 GRANTED

Related Keywords

bicevo oncology preparations pharmaceutical